Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

981
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
981
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

435
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
435
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

606
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
606
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

873
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
873
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

766
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
766
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

856
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
856

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Difficult Conversation Case: Death Notification.

Journal of education & teaching in emergency medicine·2026
Same author

Clinical Decision-Making Case: Thyroid Storm.

Journal of education & teaching in emergency medicine·2026
Same author

Procedural case: Ultrasound Case: Syncope in PE.

Journal of education & teaching in emergency medicine·2026
Same author

Managing Conflict Case: The Difficult Consultant.

Journal of education & teaching in emergency medicine·2026
Same author

Reassessment Case: Acute Pulmonary Edema in a Boarding Patient.

Journal of education & teaching in emergency medicine·2026
Same author

Enhancing Emergency Medicine Training Through Trauma-Informed Pelvic Exam Education.

Cureus·2025
Same journal

Woman with a Blackened Tongue: A Case Report.

Journal of education & teaching in emergency medicine·2026
Same journal

A Case Report on an Open Fracture Dislocation Injury of the Proximal Phalanx of the Thumb Resulting from Playing Cricket.

Journal of education & teaching in emergency medicine·2026
Same journal

Escape Intern Orientation! - A Capstone and Team Building Activity for New EM Interns.

Journal of education & teaching in emergency medicine·2026
Same journal

A Novel Low-Cost Phantom for Ultrasound-Guided Fascia Iliaca Nerve Blocks.

Journal of education & teaching in emergency medicine·2026
Same journal

The Rash That Didn't Blanch: A Case Report of Adult-Onset IgA Vasculitis with Underlying Cirrhosis and IgA Nephropathy.

Journal of education & teaching in emergency medicine·2026
Same journal

Low-Cost, Reusable Fracture Reduction Task Trainer for Distal Radius Fractures.

Journal of education & teaching in emergency medicine·2026
See all related articles

Related Experiment Video

Updated: Sep 12, 2025

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

3.6K

Beta-Blocker Toxicity.

Amrita Vempati1, P J Greene1

  • 1Creighton University School of Medicine Phoenix Program, Valleyhealth Medical Center, Department of Emergency Medicine, Phoenix, AZ.

Journal of Education & Teaching in Emergency Medicine
|August 6, 2025
PubMed
Summary
This summary is machine-generated.

This simulation effectively trained emergency medicine residents in managing beta-blocker (BB) toxicity, improving confidence in treating hypotension and bradycardia. Participants reported enhanced medical knowledge and patient care skills after the high-fidelity simulation and debriefing.

More Related Videos

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

2.0K
Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

1.9K

Related Experiment Videos

Last Updated: Sep 12, 2025

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

3.6K
High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

2.0K
Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

1.9K

Area of Science:

  • Medical Education
  • Emergency Medicine
  • Toxicology

Background:

  • Beta-blocker (BB) toxicity is a significant cause of fatalities, presenting with severe cardiovascular symptoms like hypotension and bradycardia.
  • Emergency medicine physicians require proficiency in managing BB overdose due to its critical nature and frequent presentation in emergency departments.
  • Effective training is crucial for EM residents to confidently manage BB toxicity, including complex cases of refractory hypotension.

Purpose of the Study:

  • To evaluate the effectiveness of a high-fidelity simulation in educating emergency medicine (EM) residents on managing beta-blocker (BB) toxicity.
  • To assess the impact of simulation-based training on learners' confidence in managing undifferentiated hypotension and BB overdose.
  • To reinforce key management concepts including hypoglycemia, bradycardia, vasopressor use, and specific BB toxicity treatments.

Main Methods:

  • A high-fidelity simulation session followed by debriefing was conducted for first-year EM residents.
  • Participants were divided into active management and observation groups to manage a simulated BB overdose case.
  • Post-session online surveys using a Likert scale assessed case believability, complexity, learning effectiveness, and confidence levels.

Main Results:

  • All ten survey respondents agreed or strongly agreed that the simulation enhanced learning, medical knowledge, and patient care skills.
  • Participants reported increased confidence in managing undifferentiated hypotension and BB toxicity after the simulation and debriefing.
  • The simulation effectively reinforced concepts like hypoglycemia treatment, bradycardia management, and the use of vasopressors and specific BB toxicity interventions.

Conclusions:

  • High-fidelity simulation provides an effective platform for training EM residents in managing beta-blocker toxicity.
  • This educational method significantly improves learners' confidence and competence in handling critical hypotension and overdose scenarios.
  • Simulation-based learning reinforces essential clinical skills and treatment algorithms for life-threatening toxicological emergencies.